openPR Logo
Press release

Biophotonics Market Set to Reach $139.37 Billion by 2031 Driven by Advances in Medical Therapeutics and Diagnostic Technologies

08-11-2025 10:06 AM CET | Media & Telecommunications

Press release from: Insightace Analytic Pvt Ltd.

Biophotonics Market

Biophotonics Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biophotonics Market- (By Application (Microscopy, See-through Imaging, Light Therapy, Biosensors, Spectro Molecular, Inside Imaging, Surface Imaging (endoscopy)), By Technology (In-vivo, In-vitro), By End-Use (Medical Therapeutics, Medical Diagnostics, Others (non-medical applications))), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Biophotonics Market is valued at US$ 61.18 Bn in 2022, and it is expected to reach US$ 139.37 Bn by 2031, with a CAGR of 9.7% during a forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1986

Biophotonics is a specialized discipline centered on the use of light and related radiant energy to visualize, detect, and manipulate biological materials. This field facilitates the examination of cellular and tissue structures and functions within living organisms, enabling in-depth analysis of molecular processes across micro, macro, and nanoscale levels. Biophotonics is widely applied in medical diagnostics and therapeutics, leveraging light-tissue interactions for disease detection, diagnosis, and treatment. Additionally, it is integral to the processes involving the emission, detection, absorption, reflection, modification, and generation of radiation from biomolecules, cells, tissues, organisms, and biomaterials.

The biophotonics market is anticipated to witness substantial growth over the forecast period, propelled by technological advancements in biosensors and the expanding utilization of biophotonics beyond medical applications. Increasing investments in research and development initiatives are also expected to accelerate market expansion. These factors, coupled with growing awareness of the advantages offered by biophotonics, are projected to further stimulate demand and drive sustained market growth.

List of Prominent Players in the Biophotonics Market:
• Oxford Instruments
• Olympus Corporation
• PitchBook
• ZoomInfo Technologies LLC
• Lumenis Be Ltd
• IDEX
• Zenalux Biomedical, Inc.
• GLENBROOK TECHNOLOGIES
• Photonics Media
• Thermo Fisher Scientific Inc.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics:
Drivers:
Recent technological advancements, especially within the medical field, are expected to significantly propel market demand in the coming years. The ongoing development of nanotechnology and the rising demand for home-based Point-of-Care (POC) devices are anticipated to drive short-term growth. Additionally, enhancements in optical technologies across aerospace and telecommunications sectors, alongside increased investment in research and development (R&D) from both public and private entities, are projected to further accelerate market expansion.

Challenges:
Market growth is constrained by the high costs associated with biophotonics devices and the inherent technological complexity of these systems. Slow commercialization rates and resistance to adopting novel therapeutic methods also present barriers to wider adoption. Biophotonics technologies often necessitate specialized, sophisticated equipment, which can be costly to design, produce, and maintain. Furthermore, the absence of standardized protocols and methodologies within the biophotonics domain may hinder data interpretation and reduce consistency and comparability across different studies and platforms.

Regional Trends:
North America is expected to dominate the biophotonics market, exhibiting a strong compound annual growth rate (CAGR) over the forecast period. The technology has gained considerable acceptance within the region's healthcare sector, with advanced imaging modalities such as fluorescence microscopy and optical coherence tomography (OCT) being extensively employed in diagnostics, disease management, and surgical procedures.

The growing need for point-of-care diagnostics, especially in underserved rural and remote locations, has spurred the development and adoption of portable and handheld biophotonics diagnostic devices. Concurrently, the Asia Pacific region is poised for significant market growth, driven by rapid economic development, improvements in healthcare infrastructure, and increased healthcare expenditure, all of which support greater market penetration.

Recent Developments:
• In May 2023, Olympus has just received clearance from the Food and Drug Administration (FDA) for its novel endoscopy system and the corresponding endoscopes that are compatible with it. The EVIS X1TM endoscopy device provides physicians with novel methods for visualising gastrointestinal architecture in order to diagnose, treat, and monitor diseases and disorders of the gastrointestinal tract.
• In May 2021, Thermo Fisher Scientific facilitated the advancement of complex materials research at Monash University through the provision of a specialised 300kV scanning transmission electron microscope (STEM). The Thermo Scientific Spectra φ was specifically designed to offer improved electron beam versatility in order to maximise the advanced imaging of intricate material systems.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1986

Segmentation of Biophotonics Market-
By Application-
• Microscopy
• See-through Imaging
• Light Therapy
• Biosensors
• Spectro Molecular
• Inside Imaging
• Surface Imaging (endoscopy)
By Technology-
• In-vivo
• In-vitro
By End-Use-
• Medical Therapeutics
• Medical Diagnostics
• Others (non-medical applications)
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/biophotonics-market/1986

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biophotonics Market Set to Reach $139.37 Billion by 2031 Driven by Advances in Medical Therapeutics and Diagnostic Technologies here

News-ID: 4139663 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5.3% CAGR Amid Rising Awareness of PCOS and PMS
Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market- (By Product Type (Combined Nutritional Supplements, Single Nutritional Supplements), By Type Indication (Perimenopause, PMS), By Formulation (Capsules/Tablets, Powder, Softgels, Other), By Sales Channel (Pharmacies/Drug Stores, Online Sales Channel, Direct Sales Channel, Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North America, Europe, and Asia-Pacific
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North Ameri …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy CRO Market- (By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, Pall Corporation, 3M Company, Waters Corporation.
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioseparation Systems Market- (By Type (Centrifugation Technology, Cell Disruption Technology, Chromatography Technique, Extraction Technique, Filtration Technologies and Membrane-based Bioseparation and Precipitation), Application (Food, Life Sciences, Pharmaceutical and Biopharmaceutical)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Bioseparation Systems Market is valued at US$
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc.; Bayer AG; Nestle S.A.; GlaxoSmithKline plc.
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc. …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), By Patient Type (Infants, Adults, And Geriatric Populations), Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), End-User (Home Care Settings, Long-Term Care Facilities, And Ambulatory Surgical

All 5 Releases


More Releases for Biophotonics

Rising Demand For Minimally Invasive Surgeries Boosts Biophotonics Market: A Key …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Biophotonics Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past years, there has been a swift expansion in the size of the biophotonics market. It is projected to escalate from a market worth of $83.26 billion in 2024 to an increased value of
What's Driving the Biophotonics Market 2025-2034: Rising Demand For Minimally In …
What Are the Projections for the Size and Growth Rate of the Biophotonics Market? The size of the biophotonics market has seen swift expansion in the past few years. There's a forecasted growth from $83.26 billion in 2024 to $92.33 billion in 2025, marking a compound annual growth rate (CAGR) of 10.9%. This surge during the past years can be credited to advancements in medical imaging, the diagnosis and monitoring of
What's Driving the Biophotonics Market 2025-2034: Rising Demand For Minimally In …
What Are the Projections for the Size and Growth Rate of the Biophotonics Market? The size of the biophotonics market has seen swift expansion in the past few years. There's a forecasted growth from $83.26 billion in 2024 to $92.33 billion in 2025, marking a compound annual growth rate (CAGR) of 10.9%. This surge during the past years can be credited to advancements in medical imaging, the diagnosis and monitoring of
Biophotonics Market Revolutionizing Healthcare and Beyond: The Biophotonics Mark …
Biophotonics Market worth $139.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biophotonics Market- (By Application (Microscopy, See-through Imaging, Light Therapy, Biosensors, Spectro Molecular, Inside Imaging, Surface Imaging (endoscopy)), By Technology (In-vivo, In-vitro), By End-Use (Medical Therapeutics, Medical Diagnostics, Others (non-medical applications))), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the
Biophotonics Market: Illuminating Growth and Advancements
The biophotonics market has experienced rapid growth, advancing from $74.36 billion in 2023 to an estimated $82.74 billion in 2024, reflecting a compelling Compound Annual Growth Rate (CAGR) of 11.3%. The trajectory remains promising, with projections foreseeing a substantial surge to $130.07 billion by 2028, driven by a robust CAGR of 12.0%. Minimally Invasive Surgeries Driving Demand: The market is witnessing a surge propelled by the escalating demand for minimally invasive surgeries.
Biophotonics Market worth $63.1 Billion by 2022
The global market size is estimated to reach $63.1 billion by 2022 from $31.6 billion in 2015, growing at a CAGR of 10.4% from 2016 to 2022. In 2015, North America dominated with over 37% share of the overall market, and is anticipated to continue this trend during the forecast period. Biophotonics is a technology used to produce and harness light to visualize, detect, and manipulate biological materials. The global biophotonics